HOME - Clinical cases - Periodontology
 
 
01 June 2026

Efficacy of subgingival irrigation with chemical agents as adjuvants to non-surgical periodontal therapy: systematic review and meta-analysis.


This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.

Abstract

OBJECTIVE: This systematic review aims to assess the efficacy of chemical agents (CA) in subgingival irrigation as an adjunct to non-surgical periodontal treatment (NSPT) in the treatment of periodontitis.

METHODS: Search strategies were developed for MEDLINE via PubMed, Web of Science, and LILACS databases for publications up to March 2025. Risk of bias was assessed according to the RoB 2.0 tool. Random-effects meta-analyses were conducted for clinical attachment level (CAL), probing pocket depth (PPD), and bleeding on probing (BOP).

RESULTS: From 1244 studies initially screened, 16 randomized clinical trials were included for qualitative and quantitative analyses. Studies assessed the effects of the following chemical agents: Povidone-iodine (PVP-I), Essential Oils (EOs); Chlorhexidine (CHX), Ozonated water (OW) and Boric Acid (BA). Overall, the meta-analysis showed that the adjunctive use of CA as subgingival irrigation did not provide additional benefit in PPD reduction, CAL gain, and BOP compared with controls (P > 0.05). Most studies raised some concerns with risk of bias, and 2 showed a high risk of bias.

CONCLUSION: Adjunctive use of chemical agents in subgingival irrigation during NSPT for periodontitis patients does not appear to provide additional benefit over NSPT alone, although evidence levels are low to very low.

CLINICAL RELEVANCE: CA are frequently used as adjuncts to NSPT, despite uncertainty regarding their real clinical contribution. The findings of this study help clinicians make more evidence-based decisions and avoid unnecessary use of adjunctive subgingival irrigation strategies during periodontal treatment.

Key takeaway

Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.

Introduction from full text

Chlorhexidine (CHX) is a commonly used antiseptic in situations of limited oral hygiene ability such as after periodontal surgery. However, CHX is also considered as a possible factor in the emergence of cross-resistance to antibiotics. The aim of this study was to analyze the changes in the oral microbiota and the prevalence of antimicrobial resistance genes (ARGs) due to CHX treatment.

Peer-reviewed source

Marcela Iunes da Silveira, Clarissa Carvalho Martins Maciel, Melissa M Grant, Iain L C Chapple, Andrea Carvalho De Marco, Emanuel da Silva Rovai

Clinical oral investigations. 2026

DOI: 10.1111/idh.12617

PMID: 42126682

PubMed: https://pubmed.ncbi.nlm.nih.gov/42126682/

Image: Caroline LM (Unsplash)

Related articles

This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...


This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...


This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...


This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...


This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment...


Read more

George Freedman gives readers a brief summary of products that have re­cent­ly been in­troduced to den­tistry, based on his clinical experience.


Partnership leverages BioHorizons’ commercial network to broaden availability of Xtant’s allogeneic growth factor technology, OsteoFactor Pro™, which BioHorizons will private brand


(“Sonendo” or the “Company”), a leading dental technology company and developer of the GentleWave® System, recently announced several key initiatives to support the drive toward ca


The forerunner of what’s now Texas A&M College of Dentistry opened 120 years ago in Dallas with the mission of educating dentists to provide quality care to patients in North Texas


This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...


 
 
 
 

 
 
 
 

Most popular

 
 

Events